http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014106988-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424 |
| filingDate | 2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014106988-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITIONS CONTAINING A BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR |
| abstract | 1. A pharmaceutical composition comprising a pharmaceutically effective amount of: a) at least one beta-lactam antibiotic or its pharmaceutically acceptable salt, b) sulbactam or its pharmaceutically acceptable salt, and c) at least one beta-lactamase inhibitor or its pharmaceutically acceptable salt provided that the beta-lactamase inhibitor is not sulbactam. 2. The pharmaceutical composition of claim 1, wherein the composition is in the form of a powder or solution. The pharmaceutical composition of claim 1, wherein the beta-lactam antibiotic or a pharmaceutically acceptable salt thereof is contained in an amount of from about 0.01 to about 10 g. The pharmaceutical composition of claim 1, wherein the sulbactam or a pharmaceutically acceptable salt thereof is contained in an amount of from about 0.01 to about 10 g. The pharmaceutical composition of claim 1, wherein the beta-lactamase inhibitor or a pharmaceutically acceptable salt thereof is contained in an amount of from about 0.01 to about 10 g. A method for the prevention or treatment of a bacterial infection in an individual, comprising administering to said individual a pharmaceutically effective amount of a pharmaceutical composition according to claim 1.7. A method for preventing or treating a bacterial infection in an individual, wherein said infection is caused by bacteria that produce one or more beta-lactamase enzymes, comprising administering to said individual a pharmaceutically effective amount of a pharmaceutical composition according to claim 1.8. The pharmaceutical composition of claim 1, wherein the beta-lactam antibiotic or its pharmaceutically acceptable salt, sulbactam or its pharmaceutically |
| priorityDate | 2011-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.